Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting
January 08, 2025 18:12 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
December 09, 2024 08:00 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
November 12, 2024 08:00 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results
November 07, 2024 16:05 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
October 25, 2024 08:00 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
October 24, 2024 08:00 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
October 16, 2024 16:30 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
October 10, 2024 16:05 ET
|
Senseonics Holdings, Inc.
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
September 17, 2024 07:00 ET
|
Senseonics Holdings, Inc.
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use,...
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
September 06, 2024 16:05 ET
|
Senseonics Holdings, Inc.
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...